Sonoma Pharmaceuticals (SNOA) has entered into an amendment to its distribution agreement with a leading global healthcare distributor for the marketing and distribution of its wound care products in Canada. As previously announced, on August 19, 2024, Sonoma entered into a distribution agreement with a global healthcare distributor for the marketing and distribution of its wound care products in the United States, to be sold through hospital systems and other healthcare channels. The new amendment allows the same distributor to also distribute these products in Canada, and adds over-the-counter wound care products for sale in both countries.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SNOA:
- Sonoma Pharmaceuticals regains compliance with Nasdaq requirement
- Sonoma receives FDA clearance for expanded indications for Microcyn solution
- Sonoma Pharmaceuticals, EMC Pharma enter co-marketing collaboration
- Sonoma Pharmaceuticals trading halted, news pending
- Sonoma Pharmaceuticals Stockholders Decide on Key Governance Issues